CenterWatch

Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Hematology | Family Medicine
Disease Category: Anemia
Location: United States, NY

Clinical Trial Details

Overview

Research Study Summary

Entrance into the International Fanconi Anemia Registry (IFAR)

Purpose

To obtain clinical and genetic information on patients with this heterogeneous disorder, in order to learn how to optimize growth and development of affected children, and to increase our understanding of this rare syndrome.

Patients affected with Fanconi anemia will be admitted to The Rockefeller University Hospital for 3-5 days. They will receive a complete physical examination and drawing of blood for various laboratory studies. Consultations with subspecialists in genetics, hematology, endocrinology, gastroenterology, neurology, dermatology, etc. will be obtained as warranted. Genetic counseling and dietary instruction will be provided. Since growth failure associated with endocrine abnormalities is one of the most common findings in FA, and one of the least studied, we will evaluate patients for growth hormone, glucose metabolism, thyroid function, adrenal function and pubertal function.

To Learn more

CW ID:23169
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Facility Type
N/A

Contact

Agata Smogorzewska, M.D., Ph.D.
The Rockefeller University Hospital
1230 York Avenue
New York, NY 10065
Phone: (212) 327-7850

View Map

Research Center Information: The Rockefeller University Hospital

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.